Bibliografia
1. Shetty K, Gilbert K. Dental considerations in the management of the cardiac transplant patient. Gen Dent 2008;56(7):727-32.
2. Guggenheimer J, Eghtesad B, Stock DJ. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:383-9.
3. Rustemeyer J, Bremerich A. Necessity of surgical dental foci treatment prior to organ transplantation and heart valve replacement. Clin Oral Invest 2007;11:171-174.
4. Borea G, Montebugnoli L, Capuzzi P, Vaccaio MA. Circulatory dynamics during dental operations in patients with heart transplants. Quintessence Int 1993;24:749-51.
5. Shaqman M, Ioannidou E, Burleson J, Hull D, Dongari-Bagtzoglou A. Periodontitis and inflammatory markers in transplant recipients. J Periodontol 2010;81(5):666-672.
6. Cameron CB, Kobrinsky N. Perioperative management of patients with Willebrand’s disease. Can J Anaesth 1990;37:341-7.
7. Gorge JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991;324:27-39.
8. Madireddi S. Thrombocytopenia and avoiding bleeding complications. Dent Today 2009;28(12):56-58.
9. Olitsky SE. Hereditary hemorragic telangectasia: diagnosis and management. Am Fam Physician 2010;82(7):785-90.
10. Peery WH. Clinical spectrum of hereditary haemorrhagic telangiectasia. Am J Med 1987;82:989-97.
11. Griffiths MJ, Sherani M, Scully C. Screening for anaemia in persons requiring in-patients dento-alveolar surgery. Health Trends 1992;24:128-30.
12. Young NS. Aplastic anaemia. Lancet 1995;346:228-32.
13. Valdez JM, Scheinberg P, Nunez O, Wu CO, Young NS, Walsh TJ. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis 2011 Mar; 52(6):726-35.
14. Peterson PK. A prospective study of infectious disease following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect Control 1983;4:81-9.
15. Meier JK, Wolf D, Pavletic S, Greinix H, Gosau M, Bertz H, Lee SJ, Lawitschka A, Elad S. Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig 2011;15(2):127-39.
16. Eckardt KU, Casadevall N. Pure red cell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 2003;18:865-69.
17. Da Fonseca M, Oueis HS, Casamassimo PS. Sickle cell anemia: a review for the pediatric dentist. Pediatr Dent 2007;29(2):159-169.
18. Duggal MS, Bedi R, Kinsey SE, Williams SA. The dental management of children with sickle cell disease and B-thalassemia: a review. Int J Paediat Dent 1996;6:227-34.
19. Gomber S, Dewan P. Physical growth patterns and dental caries in thalassemia. Indian Pediatr 2006;43(12):1064-9.
20. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006;107(9):2099-107.
21. Rozman C, Montserrat E. Chronic lymphocytic leucemia. N Engl J Med 1995;333:1052-7.
22. Schaedel R, Goldberg MH. Chronic lymphocytic leukemia of B-Cell Origin: oral manifestations and dental treatment planning. J Am Dent Assoc 1997;128(2):206-10.
23. Veronese L, Tchirkov A, Gouas L, Perissel B, Goumy C, Vago P. Prognosis of chronic lymphocytic leukemia: focus on recent biomarkers. Ann Biol Clin 2008;66(4):371-7.
24. Bennet JM. The French, American British (FAB) cooperative group proposals for the classifications of myelodyplastic syndromes. Br J Haematol 1982;51:189-99.
25. Musolino C, Sant’Antonio E, Penna G, Alonci A, Russo S, Granata A, Allegra A. Epigenetic therapy in myelodysplastic syndromes. Eur J Haematol 2010;84(6):463-73.
26. Pession A, Melchionda F, Morello W, Farruggia P, Aricò M. Sindromi ipereosinofile. Hematology Meeting Reports 2007;1(6):67-74.
27. Pardanani A, Tefferi A. Targeting myeloproliferative neoplasms with JAK inhibitors. Curr Opin Hematol Mar;18(2):105-10.
28. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol 2007;139(5):730-43.
29. Haytac MC, Dogan MC, Antmen B. The results of a preventive dental program for pediatric patients with hematologic malignancies. Oral Health Prev Dent 2004;2(1):59-65.
30. Armitage JO. Treatment of non-Hodgkin’s lymphomas. N Engl J Med 1993;328:1023-30.
31. Allen CE, McClain KL. Langerhans cell histiocytosis: a review of past, current and future terapies. Drugs Today 2007 Sep;43(9):627-43.
32. Ferguson GT, Cherniack RM. Management of chronic obstructive polmonare disease. N Engl J Med 1993;328:1017-22.
33. Venables PJ. Management of patients presenting with Sjogren’s syndrome. Best Pract Res Clin Rheumatol 2006;20(4):791-807.
34. Porter SR, Scully C. Periodontal aspects of systemic disease – classifications. In Lang NP and Karring T (eds), Proceeding of the 1st European Workshop on Periodontology. Berlin: Quintessence, 1994;375-414.
35. Pizzo G, Guiglia R, Lo Russo L, Campisi G. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur J Intern Med 2010 Dec;21(6):496-502.
36. Iredale JP. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ 2003;327:143-7.
37. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011;56(4):958-76.
38. Byron RJ Jr, Osborne PD. Dental Management of liver transplant patients. Gen Dent 2005;53(1):66-9.
39. Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics 2010;41(5):199-208.
40. Fisher MA, Borgnakke WS, Taylor GW. Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease. Curr Opin Nephrol Hypertens 2010;19(6):519-26.
41. Eigner TL, Jastak JT, Bennet WM. Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc 1986;113:612-6.
42. Somma F, Castagnola R, Bollino D, Marigo L. Oral inflammatory process and general health. Part 1: The focal infection and the oral inflammatory lesion. Eur Rev MEd Pharmacol Sci 2010;14(12):1085-95.
43. Mammis A, Eloy JA, Liu JK. Early descriptions of acromegaly and gigantism and their historical evolution as clinical entities. Neurosurg Focus 2010;29(4):E1.
44. Mancini T, Porcelli T, Giustina A. Treatment of cushing disease: overview and recent findings. Ther Clin Risk Manag 2010;6:505-16.
45. Pinto A, Glick M. Management of patients with thyroid disease: oral health considerations. J Am Dent Assoc 2002;133(7):849-58.
46. Lamster IB, Lalla E, Borgnakke WS, Taylor GW. The relationship between oral health and diabetes mellitus. J Am Dent Assoc 2008;139 Suppl:19S-24S.
47. Levin JA, Muzyka BC, Glick M. Dental management of patients with diabetes mellitus. Compend Contin Educ Dent 1996;17,82-90.
48. Sivolella S, Boccuzzo G, Franco M, Stellini E, Di Fiore A, Berengo M. Influence of estroprogestinic therapy on the postoperative course following impacted third molar extraction. Minerva Stomatol 2010 Nov-Dec;59(11-12):611-23.
49. Midda M, Konig KG. Nutrition, diet and oral health. Int Dent J 1994;44:599-612.
50. Laederich MB, Horton WA. Achondroplasia: pathogenesis and implications for future treatment. Curr Opin Pediatr 2010;22(4):516-23.
51. Scaramuzzo L, Messuti L, Manicone PF, Raffaelli L, Rossi B, Gallenzi P, Berardi D, Maccauro G. Clinical and histological modifications in osteopetrotic bone: a review. J Biol Regul Homeost Agents 2009;23(2):59-63.
52. Malfait F, Wenstrup RJ, De Pape A. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 2010;12(10):597-605.
53. Hosking DJ, Meunier PJ, Ringe JD, et al. Paget’s disease of bone: diagnosis and management. Br Med J 1996;312:491-4.
54. Newman KA, Akhtari M. Management of autoimmune neutropenia in Felty’s syndrome and systemic lupus erythematosus. Autoimmun Rev 2011;10(7):432-7.
55. Hazes JMW, Silman AJ. Review of UK data on the rheumatic diseases: 2. Rheumatoid arthritis. Br J Rheumatol 1990;29:310-2.
56. Torgerson TR. Immune dysregulation in primary immunodeficiency disorders. Immunol Allergy Clin North Am 2008;28(2):315-27.
57. Smith JA. HIV and AIDS in the adolescent and adult: an update for the oral and maxillofacial surgeon. Oral Maxillofac Surg Clin North Am 2008;20(4):535-65.
58. Ritter AV, Patton L. HIV/AIDS and oral health. J Esthet Restor Dent 2007;19(5):297-8.
59. Ergun S, Katz J, Cifter ED, Koray M, Esen BA, Tanyeri H. Implantsupported oral rehabilitation of a patient with systemic lupus erythematosus: case report and review of the literature. Quintessence Int 2010;41(10):863-7.
60. Feber T. Mouth care for patients receiving oral irradiation. Prof Nurse 1995;10(10):666-70.
61. Jham BC, da Silva Freire AR. Oral complications of radiotherapy in the head and neck. Braz J Otorhinolaryngol 2006;72(5):704-8.
62.Thomson PJ, Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 6 – cancer, radiotherapy and chemiotherapy. British Dental Journal 2010;209:65-69.
63.Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 2002;28(1):65-74.
64. Demarosi F, Bez C, Carrassi A. Prevention and treatment of chemo- and radiotherapy- induced oral mucositis. Minerva Stomatol 2002;51(5):173-86.
65. Farbod F, Kanaan H, Farbod J. Infective endocarditis and antibiotic prophylaxis prior to dental/oral procedures: latest revision to the guidelines by the American Heart Association 2007. Int J Oral Maxillofac Surg 2009;38:626-631.
66. Berchier CE, Slot DE, Van der Weijden GA. The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. J Clin Periodontol 2010;37:829-839.
67. Meyer U, Weingart D, Deng MC, Scheld HH, Joos U. Heart transplants-assessment of dental procedures. Clin Oral Investig 1999;3:79-83.
68.Velich N, Remport A, Szabo G. Dental screening of patients after organ transplantation. Orv Hetil 2002;10:505-50.
